A platform to speed new neurotechnology treatments for brain and spinal cord injury
Official title: Bridging bench to bedside with aneurotechnology cross-development platform
Funded at Providence VA Medical Center · NIH-11251747 · Data updated 2026-11-12
Building tools to move promising brain and spinal cord devices from the lab into care faster for Veterans and others with neurological injuries.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Providence VA Medical Center NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | February 1, 2023 |
| Project end | September 30, 2027 |
| Funding year | 2026 |
| NIH project number | 5I01RX004250-04 |
| Project ID | NIH-11251747 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates would include Veterans and others living with traumatic brain injury, spinal cord injury, or related neurological disorders who might be candidates for device-based treatments.
✕Less likely to help
People without neurological conditions or those who are not eligible for device-based therapies (for medical or personal reasons) are unlikely to benefit directly from this effort.
What this research studies
This project creates a cross-development platform to help engineers and clinicians combine and test neurotechnology components more quickly and safely. The team will develop methods, hardware and processes that bridge lab prototypes to devices that can be used in patients. Work is focused on therapies for people with traumatic brain and spinal cord injuries and will be coordinated through the Providence VA Medical Center. The aim is to shorten the long timelines that currently delay new medical devices reaching patients.
Why it matters
Potential benefit: If successful, this could bring safer, effective neurodevices to people with brain and spinal cord injuries sooner and more reliably.
How similar studies have gone: There have been successful device therapies in the past like deep brain stimulation, but using a coordinated platform to accelerate many neurotechnology advances is a relatively new approach.
Where this research is happening
-
Providence VA Medical Center
Providence, United States Active
Researchers
- Principal investigator: Borton, David Allenson — Providence VA Medical Center
- Study coordinator: Borton, David Allenson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.